VC
TECX

Vivo Capital’s Tectonic Therapeutic TECX Stock Holding History

Vivo Capital’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-17,185
Closed -$2.69M – 68
2020
Q3 		$2.69M Sell
17,185
-3,950
-19% -$796K 0.16% 58
2020
Q2 		$4.43M Sell
21,135
-38,678
-65% -$7.97M 0.32% 47
2020
Q1 		$11.2M Buy
+59,813
New +$14.1M 1.01% 32

Other funds holding TECX

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Vivo Capital's TECX Position: Q4 2020 in Review

Vivo Capital sold out of Tectonic Therapeutic (TECX) in Q4 2020, closing a stake of 17,185 shares — an estimated $2.69M sold.

Vivo Capital first reported a position in TECX in Q1 2020 and held it in 3 quarters. The position peaked at $11.2M in Q1 2020. 105 funds tracked by Wall St. Rank hold TECX as of Q4 2020.

  • Vivo Capital reported no remaining Tectonic Therapeutic position as of Q4 2020 after selling out during the quarter.
  • Vivo Capital sold 17,185 Tectonic Therapeutic shares in Q4 2020, an estimated $2.69M.
  • Vivo Capital first reported a position in Tectonic Therapeutic in Q1 2020 and held it in 3 quarters.
  • Vivo Capital's Tectonic Therapeutic position peaked at $11.2M in Q1 2020.
  • 105 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q4 2020.

Based on Vivo Capital's 13F filing for Q4 2020, filed 16 Feb 2021.